PLADIENOLIDE PYRIDINE COMPOUNDS AND METHODS OF USE

The present invention provides novel pladienolide pyridine compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancer, particularly cancers in which agents that target the splic...

Full description

Saved in:
Bibliographic Details
Main Authors BAUDOUIN GERARD, XIANG LIU, JOHN WANG, MICHAEL P. THOMAS, KENZO ARAI, GUO ZHU ZHENG, SUDEEP PRAJAPATI, NICHOLAS C. GEARHART, PARCHAREE TIVITMAHAISOON, MASAYUKI MIYANO, LIHUA YU, BETTY CHAN, KIAN HUAT LIM, KAZUNOBU KIRA, SATOSHI NAGAO, GREGG F. KEANEY, REGINA KANADA SONOBE, ERMIRA PAZOLLI, YOSHIHIKO KOTAKE, NORIO MURAI, SILVIA BUONAMICI, PETER G. SMITH, EUNICE SUN PARK
Format Patent
LanguageEnglish
Portuguese
Published 27.02.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel pladienolide pyridine compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancer, particularly cancers in which agents that target the spliceosome and mutations therein are known to be useful.
Bibliography:Application Number: PT20150727125T